top of page

Tokyo based TMS has a lead program that aims to be the first new medicine for acute ischemic stroke in decades

  • blonca9
  • Nov 13, 2024
  • 1 min read

CEO Takuro Wakabayashi describes the unmet need in stroke and how this asset found its way into to a partnership with RTW-based Corxel. Plus, further pipeline programs covering hypertension, kidney injury, and spinal cord injury.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page